Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study
Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study (VNS-EPS)
Northwell Health
10 participants
Aug 22, 2022
INTERVENTIONAL
Conditions
Summary
The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.
Eligibility
Inclusion Criteria1
- Primary indication for EPS for the evaluation of cardiac conduction system or supraventricular tachycardia.
Exclusion Criteria9
- Previous EPS with ablation
- Previous failed ablation
- Known conduction system disease, right or left bundle branch block on EKG
- Pregnant women
- History of postural orthostatic tachycardia syndrome
- Patients who have had prior cervical vagotomy
- Patients with skin on the tragus that is broken or cracked
- Patients with a history of baseline cardiac disease or atherosclerotic cardiovascular disease, including congestive heart failure (CHF), known severe coronary artery disease or recent myocardial infarction (within 5 years) and patients diagnosed with narrowing of the arteries (carotid atherosclerosis)
- Patients with an active implantable medical device, such as a cardiac pacemaker, hearing aid implant, or any implanted metallic, implanted vagus nerve stimulator or electronic device.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Parasym device will be placed on the patient's left tragus to provide transcutaneous electrical stimulation to the auricular branch of the vagus nerve.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05350150